Home Healthcare Biotechnology Influenza Diagnostics Market

Influenza Diagnostics Market Size, Share & Trends Analysis Report By Test Type (Traditional Diagnostic Test, Molecular Diagnostic Test), By Influenza Type (Influenza A, Influenza B), By End-User (Hospital, Point-of-Care Testing, Diagnostic Centers, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 05, 2026 | Author: Jay Mehta | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Influenza Diagnostics Market, By Test Type 2022-2034 (USD MILLION/ Units)
    1. Traditional Diagnostic Test
      1. RIDT
      2. Cell Culture
      3. DFA
      4. Serological Assays
    2. Molecular Diagnostic Test
      1. RT-PCR
      2. INNAT
        1. TMA
        2. LAMP
        3. NASBA
        4. Other INNAT
      3. Other Molecular Tests
  2. Influenza Diagnostics Market, By Influenza Type 2022-2034 (USD MILLION/ Units)
    1. Influenza A
    2. Influenza B
  3. Influenza Diagnostics Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Hospital
    2. Point-of-Care Testing
    3. Diagnostic Centers
    4. Others
  4. Regional Influenza Diagnostics Market
    1. North America
      1. North America Influenza Diagnostics Market By Test Type 2022-2034 (USD MILLION/ Units)
        1. Traditional Diagnostic Test
          1. RIDT
          2. Cell Culture
          3. DFA
          4. Serological Assays
        2. Molecular Diagnostic Test
          1. RT-PCR
          2. INNAT
            1. TMA
            2. LAMP
            3. NASBA
            4. Other INNAT
          3. Other Molecular Tests
      2. North America Influenza Diagnostics Market By Influenza Type 2022-2034 (USD MILLION/ Units)
        1. Influenza A
        2. Influenza B
      3. North America Influenza Diagnostics Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospital
        2. Point-of-Care Testing
        3. Diagnostic Centers
        4. Others
      4. U.S.
        1. Traditional Diagnostic Test
          1. RIDT
          2. Cell Culture
          3. DFA
          4. Serological Assays
        2. Molecular Diagnostic Test
          1. RT-PCR
          2. INNAT
            1. TMA
            2. LAMP
            3. NASBA
            4. Other INNAT
          3. Other Molecular Tests
        3. Influenza A
        4. Influenza B
        5. Hospital
        6. Point-of-Care Testing
        7. Diagnostic Centers
        8. Others
      5. Canada
        1. Traditional Diagnostic Test
          1. RIDT
          2. Cell Culture
          3. DFA
          4. Serological Assays
        2. Molecular Diagnostic Test
          1. RT-PCR
          2. INNAT
            1. TMA
            2. LAMP
            3. NASBA
            4. Other INNAT
          3. Other Molecular Tests
        3. Influenza A
        4. Influenza B
        5. Hospital
        6. Point-of-Care Testing
        7. Diagnostic Centers
        8. Others
    2. Europe
      1. Europe Influenza Diagnostics Market By Test Type 2022-2034 (USD MILLION/ Units)
        1. Traditional Diagnostic Test
          1. RIDT
          2. Cell Culture
          3. DFA
          4. Serological Assays
        2. Molecular Diagnostic Test
          1. RT-PCR
          2. INNAT
            1. TMA
            2. LAMP
            3. NASBA
            4. Other INNAT
          3. Other Molecular Tests
      2. Europe Influenza Diagnostics Market By Influenza Type 2022-2034 (USD MILLION/ Units)
        1. Influenza A
        2. Influenza B
      3. Europe Influenza Diagnostics Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospital
        2. Point-of-Care Testing
        3. Diagnostic Centers
        4. Others
      4. U.K.
        1. Traditional Diagnostic Test
          1. RIDT
          2. Cell Culture
          3. DFA
          4. Serological Assays
        2. Molecular Diagnostic Test
          1. RT-PCR
          2. INNAT
            1. TMA
            2. LAMP
            3. NASBA
            4. Other INNAT
          3. Other Molecular Tests
        3. Influenza A
        4. Influenza B
        5. Hospital
        6. Point-of-Care Testing
        7. Diagnostic Centers
        8. Others
      5. Germany
        1. Traditional Diagnostic Test
          1. RIDT
          2. Cell Culture
          3. DFA
          4. Serological Assays
        2. Molecular Diagnostic Test
          1. RT-PCR
          2. INNAT
            1. TMA
            2. LAMP
            3. NASBA
            4. Other INNAT
          3. Other Molecular Tests
        3. Influenza A
        4. Influenza B
        5. Hospital
        6. Point-of-Care Testing
        7. Diagnostic Centers
        8. Others
      6. France
        1. Traditional Diagnostic Test
          1. RIDT
          2. Cell Culture
          3. DFA
          4. Serological Assays
        2. Molecular Diagnostic Test
          1. RT-PCR
          2. INNAT
            1. TMA
            2. LAMP
            3. NASBA
            4. Other INNAT
          3. Other Molecular Tests
        3. Influenza A
        4. Influenza B
        5. Hospital
        6. Point-of-Care Testing
        7. Diagnostic Centers
        8. Others
      7. Spain
        1. Traditional Diagnostic Test
          1. RIDT
          2. Cell Culture
          3. DFA
          4. Serological Assays
        2. Molecular Diagnostic Test
          1. RT-PCR
          2. INNAT
            1. TMA
            2. LAMP
            3. NASBA
            4. Other INNAT
          3. Other Molecular Tests
        3. Influenza A
        4. Influenza B
        5. Hospital
        6. Point-of-Care Testing
        7. Diagnostic Centers
        8. Others
      8. Italy
        1. Traditional Diagnostic Test
          1. RIDT
          2. Cell Culture
          3. DFA
          4. Serological Assays
        2. Molecular Diagnostic Test
          1. RT-PCR
          2. INNAT
            1. TMA
            2. LAMP
            3. NASBA
            4. Other INNAT
          3. Other Molecular Tests
        3. Influenza A
        4. Influenza B
        5. Hospital
        6. Point-of-Care Testing
        7. Diagnostic Centers
        8. Others
      9. Russia
        1. Traditional Diagnostic Test
          1. RIDT
          2. Cell Culture
          3. DFA
          4. Serological Assays
        2. Molecular Diagnostic Test
          1. RT-PCR
          2. INNAT
            1. TMA
            2. LAMP
            3. NASBA
            4. Other INNAT
          3. Other Molecular Tests
        3. Influenza A
        4. Influenza B
        5. Hospital
        6. Point-of-Care Testing
        7. Diagnostic Centers
        8. Others
      10. Nordic
        1. Traditional Diagnostic Test
          1. RIDT
          2. Cell Culture
          3. DFA
          4. Serological Assays
        2. Molecular Diagnostic Test
          1. RT-PCR
          2. INNAT
            1. TMA
            2. LAMP
            3. NASBA
            4. Other INNAT
          3. Other Molecular Tests
        3. Influenza A
        4. Influenza B
        5. Hospital
        6. Point-of-Care Testing
        7. Diagnostic Centers
        8. Others
      11. Benelux
        1. Traditional Diagnostic Test
          1. RIDT
          2. Cell Culture
          3. DFA
          4. Serological Assays
        2. Molecular Diagnostic Test
          1. RT-PCR
          2. INNAT
            1. TMA
            2. LAMP
            3. NASBA
            4. Other INNAT
          3. Other Molecular Tests
        3. Influenza A
        4. Influenza B
        5. Hospital
        6. Point-of-Care Testing
        7. Diagnostic Centers
        8. Others
      12. Rest of Europe
        1. Traditional Diagnostic Test
          1. RIDT
          2. Cell Culture
          3. DFA
          4. Serological Assays
        2. Molecular Diagnostic Test
          1. RT-PCR
          2. INNAT
            1. TMA
            2. LAMP
            3. NASBA
            4. Other INNAT
          3. Other Molecular Tests
        3. Influenza A
        4. Influenza B
        5. Hospital
        6. Point-of-Care Testing
        7. Diagnostic Centers
        8. Others
    3. APAC
      1. APAC Influenza Diagnostics Market By Test Type 2022-2034 (USD MILLION/ Units)
        1. Traditional Diagnostic Test
          1. RIDT
          2. Cell Culture
          3. DFA
          4. Serological Assays
        2. Molecular Diagnostic Test
          1. RT-PCR
          2. INNAT
            1. TMA
            2. LAMP
            3. NASBA
            4. Other INNAT
          3. Other Molecular Tests
      2. APAC Influenza Diagnostics Market By Influenza Type 2022-2034 (USD MILLION/ Units)
        1. Influenza A
        2. Influenza B
      3. APAC Influenza Diagnostics Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospital
        2. Point-of-Care Testing
        3. Diagnostic Centers
        4. Others
      4. China
        1. Traditional Diagnostic Test
          1. RIDT
          2. Cell Culture
          3. DFA
          4. Serological Assays
        2. Molecular Diagnostic Test
          1. RT-PCR
          2. INNAT
            1. TMA
            2. LAMP
            3. NASBA
            4. Other INNAT
          3. Other Molecular Tests
        3. Influenza A
        4. Influenza B
        5. Hospital
        6. Point-of-Care Testing
        7. Diagnostic Centers
        8. Others
      5. Korea
        1. Traditional Diagnostic Test
          1. RIDT
          2. Cell Culture
          3. DFA
          4. Serological Assays
        2. Molecular Diagnostic Test
          1. RT-PCR
          2. INNAT
            1. TMA
            2. LAMP
            3. NASBA
            4. Other INNAT
          3. Other Molecular Tests
        3. Influenza A
        4. Influenza B
        5. Hospital
        6. Point-of-Care Testing
        7. Diagnostic Centers
        8. Others
      6. Japan
        1. Traditional Diagnostic Test
          1. RIDT
          2. Cell Culture
          3. DFA
          4. Serological Assays
        2. Molecular Diagnostic Test
          1. RT-PCR
          2. INNAT
            1. TMA
            2. LAMP
            3. NASBA
            4. Other INNAT
          3. Other Molecular Tests
        3. Influenza A
        4. Influenza B
        5. Hospital
        6. Point-of-Care Testing
        7. Diagnostic Centers
        8. Others
      7. India
        1. Traditional Diagnostic Test
          1. RIDT
          2. Cell Culture
          3. DFA
          4. Serological Assays
        2. Molecular Diagnostic Test
          1. RT-PCR
          2. INNAT
            1. TMA
            2. LAMP
            3. NASBA
            4. Other INNAT
          3. Other Molecular Tests
        3. Influenza A
        4. Influenza B
        5. Hospital
        6. Point-of-Care Testing
        7. Diagnostic Centers
        8. Others
      8. Australia
        1. Traditional Diagnostic Test
          1. RIDT
          2. Cell Culture
          3. DFA
          4. Serological Assays
        2. Molecular Diagnostic Test
          1. RT-PCR
          2. INNAT
            1. TMA
            2. LAMP
            3. NASBA
            4. Other INNAT
          3. Other Molecular Tests
        3. Influenza A
        4. Influenza B
        5. Hospital
        6. Point-of-Care Testing
        7. Diagnostic Centers
        8. Others
      9. Taiwan
        1. Traditional Diagnostic Test
          1. RIDT
          2. Cell Culture
          3. DFA
          4. Serological Assays
        2. Molecular Diagnostic Test
          1. RT-PCR
          2. INNAT
            1. TMA
            2. LAMP
            3. NASBA
            4. Other INNAT
          3. Other Molecular Tests
        3. Influenza A
        4. Influenza B
        5. Hospital
        6. Point-of-Care Testing
        7. Diagnostic Centers
        8. Others
      10. South East Asia
        1. Traditional Diagnostic Test
          1. RIDT
          2. Cell Culture
          3. DFA
          4. Serological Assays
        2. Molecular Diagnostic Test
          1. RT-PCR
          2. INNAT
            1. TMA
            2. LAMP
            3. NASBA
            4. Other INNAT
          3. Other Molecular Tests
        3. Influenza A
        4. Influenza B
        5. Hospital
        6. Point-of-Care Testing
        7. Diagnostic Centers
        8. Others
      11. Rest of Asia-Pacific
        1. Traditional Diagnostic Test
          1. RIDT
          2. Cell Culture
          3. DFA
          4. Serological Assays
        2. Molecular Diagnostic Test
          1. RT-PCR
          2. INNAT
            1. TMA
            2. LAMP
            3. NASBA
            4. Other INNAT
          3. Other Molecular Tests
        3. Influenza A
        4. Influenza B
        5. Hospital
        6. Point-of-Care Testing
        7. Diagnostic Centers
        8. Others
    4. Middle East and Africa
      1. Middle East and Africa Influenza Diagnostics Market By Test Type 2022-2034 (USD MILLION/ Units)
        1. Traditional Diagnostic Test
          1. RIDT
          2. Cell Culture
          3. DFA
          4. Serological Assays
        2. Molecular Diagnostic Test
          1. RT-PCR
          2. INNAT
            1. TMA
            2. LAMP
            3. NASBA
            4. Other INNAT
          3. Other Molecular Tests
      2. Middle East and Africa Influenza Diagnostics Market By Influenza Type 2022-2034 (USD MILLION/ Units)
        1. Influenza A
        2. Influenza B
      3. Middle East and Africa Influenza Diagnostics Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospital
        2. Point-of-Care Testing
        3. Diagnostic Centers
        4. Others
      4. UAE
        1. Traditional Diagnostic Test
          1. RIDT
          2. Cell Culture
          3. DFA
          4. Serological Assays
        2. Molecular Diagnostic Test
          1. RT-PCR
          2. INNAT
            1. TMA
            2. LAMP
            3. NASBA
            4. Other INNAT
          3. Other Molecular Tests
        3. Influenza A
        4. Influenza B
        5. Hospital
        6. Point-of-Care Testing
        7. Diagnostic Centers
        8. Others
      5. Turkey
        1. Traditional Diagnostic Test
          1. RIDT
          2. Cell Culture
          3. DFA
          4. Serological Assays
        2. Molecular Diagnostic Test
          1. RT-PCR
          2. INNAT
            1. TMA
            2. LAMP
            3. NASBA
            4. Other INNAT
          3. Other Molecular Tests
        3. Influenza A
        4. Influenza B
        5. Hospital
        6. Point-of-Care Testing
        7. Diagnostic Centers
        8. Others
      6. Saudi Arabia
        1. Traditional Diagnostic Test
          1. RIDT
          2. Cell Culture
          3. DFA
          4. Serological Assays
        2. Molecular Diagnostic Test
          1. RT-PCR
          2. INNAT
            1. TMA
            2. LAMP
            3. NASBA
            4. Other INNAT
          3. Other Molecular Tests
        3. Influenza A
        4. Influenza B
        5. Hospital
        6. Point-of-Care Testing
        7. Diagnostic Centers
        8. Others
      7. South Africa
        1. Traditional Diagnostic Test
          1. RIDT
          2. Cell Culture
          3. DFA
          4. Serological Assays
        2. Molecular Diagnostic Test
          1. RT-PCR
          2. INNAT
            1. TMA
            2. LAMP
            3. NASBA
            4. Other INNAT
          3. Other Molecular Tests
        3. Influenza A
        4. Influenza B
        5. Hospital
        6. Point-of-Care Testing
        7. Diagnostic Centers
        8. Others
      8. Egypt
        1. Traditional Diagnostic Test
          1. RIDT
          2. Cell Culture
          3. DFA
          4. Serological Assays
        2. Molecular Diagnostic Test
          1. RT-PCR
          2. INNAT
            1. TMA
            2. LAMP
            3. NASBA
            4. Other INNAT
          3. Other Molecular Tests
        3. Influenza A
        4. Influenza B
        5. Hospital
        6. Point-of-Care Testing
        7. Diagnostic Centers
        8. Others
      9. Nigeria
        1. Traditional Diagnostic Test
          1. RIDT
          2. Cell Culture
          3. DFA
          4. Serological Assays
        2. Molecular Diagnostic Test
          1. RT-PCR
          2. INNAT
            1. TMA
            2. LAMP
            3. NASBA
            4. Other INNAT
          3. Other Molecular Tests
        3. Influenza A
        4. Influenza B
        5. Hospital
        6. Point-of-Care Testing
        7. Diagnostic Centers
        8. Others
      10. Rest of MEA
        1. Traditional Diagnostic Test
          1. RIDT
          2. Cell Culture
          3. DFA
          4. Serological Assays
        2. Molecular Diagnostic Test
          1. RT-PCR
          2. INNAT
            1. TMA
            2. LAMP
            3. NASBA
            4. Other INNAT
          3. Other Molecular Tests
        3. Influenza A
        4. Influenza B
        5. Hospital
        6. Point-of-Care Testing
        7. Diagnostic Centers
        8. Others
    5. LATAM
      1. LATAM Influenza Diagnostics Market By Test Type 2022-2034 (USD MILLION/ Units)
        1. Traditional Diagnostic Test
          1. RIDT
          2. Cell Culture
          3. DFA
          4. Serological Assays
        2. Molecular Diagnostic Test
          1. RT-PCR
          2. INNAT
            1. TMA
            2. LAMP
            3. NASBA
            4. Other INNAT
          3. Other Molecular Tests
      2. LATAM Influenza Diagnostics Market By Influenza Type 2022-2034 (USD MILLION/ Units)
        1. Influenza A
        2. Influenza B
      3. LATAM Influenza Diagnostics Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospital
        2. Point-of-Care Testing
        3. Diagnostic Centers
        4. Others
      4. Brazil
        1. Traditional Diagnostic Test
          1. RIDT
          2. Cell Culture
          3. DFA
          4. Serological Assays
        2. Molecular Diagnostic Test
          1. RT-PCR
          2. INNAT
            1. TMA
            2. LAMP
            3. NASBA
            4. Other INNAT
          3. Other Molecular Tests
        3. Influenza A
        4. Influenza B
        5. Hospital
        6. Point-of-Care Testing
        7. Diagnostic Centers
        8. Others
      5. Mexico
        1. Traditional Diagnostic Test
          1. RIDT
          2. Cell Culture
          3. DFA
          4. Serological Assays
        2. Molecular Diagnostic Test
          1. RT-PCR
          2. INNAT
            1. TMA
            2. LAMP
            3. NASBA
            4. Other INNAT
          3. Other Molecular Tests
        3. Influenza A
        4. Influenza B
        5. Hospital
        6. Point-of-Care Testing
        7. Diagnostic Centers
        8. Others
      6. Argentina
        1. Traditional Diagnostic Test
          1. RIDT
          2. Cell Culture
          3. DFA
          4. Serological Assays
        2. Molecular Diagnostic Test
          1. RT-PCR
          2. INNAT
            1. TMA
            2. LAMP
            3. NASBA
            4. Other INNAT
          3. Other Molecular Tests
        3. Influenza A
        4. Influenza B
        5. Hospital
        6. Point-of-Care Testing
        7. Diagnostic Centers
        8. Others
      7. Chile
        1. Traditional Diagnostic Test
          1. RIDT
          2. Cell Culture
          3. DFA
          4. Serological Assays
        2. Molecular Diagnostic Test
          1. RT-PCR
          2. INNAT
            1. TMA
            2. LAMP
            3. NASBA
            4. Other INNAT
          3. Other Molecular Tests
        3. Influenza A
        4. Influenza B
        5. Hospital
        6. Point-of-Care Testing
        7. Diagnostic Centers
        8. Others
      8. Colombia
        1. Traditional Diagnostic Test
          1. RIDT
          2. Cell Culture
          3. DFA
          4. Serological Assays
        2. Molecular Diagnostic Test
          1. RT-PCR
          2. INNAT
            1. TMA
            2. LAMP
            3. NASBA
            4. Other INNAT
          3. Other Molecular Tests
        3. Influenza A
        4. Influenza B
        5. Hospital
        6. Point-of-Care Testing
        7. Diagnostic Centers
        8. Others
      9. Rest of LATAM
        1. Traditional Diagnostic Test
          1. RIDT
          2. Cell Culture
          3. DFA
          4. Serological Assays
        2. Molecular Diagnostic Test
          1. RT-PCR
          2. INNAT
            1. TMA
            2. LAMP
            3. NASBA
            4. Other INNAT
          3. Other Molecular Tests
        3. Influenza A
        4. Influenza B
        5. Hospital
        6. Point-of-Care Testing
        7. Diagnostic Centers
        8. Others
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.